Skip to main content

The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis

Abstract:

Studies of oral corticosteroid dose and loss of bone mineral density have reported inconsistent results. In this meta-analysis, we used information from 66 papers on bone density and 23 papers on fractures to examine the effects of oral corticosteroids on bone mineral density and risk of fracture. Strong correlations were found between cumulative dose and loss of bone mineral density and between daily dose and risk of fracture. The risk of fracture was found to increase rapidly after the start of oral corticosteroid therapy (within 3 to 6 months) and decrease after stopping therapy. The risk remained independent of underlying disease, age and gender. We conclude that oral corticosteroid treatment using more than 5 mg (of prednisolone or equivalent) daily leads to a reduction in bone mineral density and a rapid increase in the risk of fracture during the treatment period. Early use of preventive measures against corticosteroid-induced osteoporosis is recommended.

This is a preview of subscription content, access via your institution.

Author information

Affiliations

Authors

Additional information

Received: 14 January 2001 / Accepted: 25 March 2002

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Staa, T., Staa, T., Staa, T. et al. The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis . Osteoporos Int 13, 777–787 (2002). https://doi.org/10.1007/s001980200108

Download citation

  • Key words:Bone – Bone density – Fracture – Glucocorticoids – Iatrogenic disease – Meta-analysis – Review